The REAL.FR research program on Alzheimer's disease and its management: Methods and preliminary results

Journal of Nutrition, Health and Aging

Volumn 7, Issue 2, 2003, Pages 91-96

  Gillette Guyonnet, S ^a,b   Nourhashemi, F ^a,b   Andrieu, S ^b   Cantet, C ^b   Micas, M ^a   Ousset, P J ^a   Vellas, B ^a,b   Rainfray, M ^c   Emeriau, J P ^c   Franco, A ^c   Pasquier, F ^c   Frigard, B ^c   Michel, B ^c   Jeandel, C ^c   Touchon, J ^c   Robert, P ^c   Brocker, P ^c   Forette, B ^c   Lechowski, L ^c   Belmin, J ^c   Verny, M ^c   Forette, F ^c   Rigaud, A S ^c   Jouanny, P ^c   Belliard, S ^c   Michel, O ^c   Gonthier, R ^c   more..

^a Pavillon Junod   (France)

^b INSERM   (France)

^c NONE

Author keywords

Aging; Alzheimer's disease; Burden; Care giver; Dementia; Elderly; Modalities of management; Natural history; Nutrition; REAL.FR

Indexed keywords

CHOLINESTERASE INHIBITOR;

AGED; ALZHEIMER DISEASE; ARTICLE; CAREGIVER; CLINICAL RESEARCH; COGNITIVE DEFECT; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; FAMILY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL STATUS; PATIENT SELECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SOCIAL SUPPORT;

EID: 0037272817     PISSN: 12797707     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Jost B.C., Grossberg G.T., The natural history of Alzheimer's disease: a brain bank study, J. Am. Geriatr. Soc., 1995, 43: 1248-1255.
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th ed) (DSM-IV). APA. Washington DC, 1994.
3. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M., Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease, Neurology, 1984, 34: 939-944.
4. Agence National d'Accréditation et d'Evaluation en Santé, Recommandations pratiques pour le diagnostic de la maladie d'Alzheimer. February 2000.
5. Katz S., Ford A., Moskowitz R., The index of ADL, a standardized measure of biological and psychosocial function. JAMA, 1963, 18: 914-919.
6. Lawton M.P., Brody E.M., Assessment of older people: self- maintaining and instrumental activities of daily living, Gerontologist, 1969, 9: 179-186.
7. Folstein M.F., Folstein S.E., McHugh P.R., "Mini-Mental State". A practical method for grading the cognitive state of patients for the clinician, J. Psychiatr. Res., 1975, 12: 189-198.
8. Rosen W.G., Mohs R.C., Davis K.L., A new rating scale for Alzheimer's disease, Am. J. Psychiatry, 1984, 141: 1356-1364.
9. Reisberg B., Ferris S.H., de Leon M.J., Crook T., The Global Deterioration Scale for assessment of primary degenerative dementia, Am. J. Psychiatry, 1982, 139: 1136-1139.
10. Hughes C.P., Berg L., Dantziger W.L., Coben L.A., Martin R.L., A new clinical scale for the staging of dementia, Br. J. Psychiatry, 1982, 140: 566-572.
11. Cummings J.L., Mega M., Gray K., Rosenberg-Thompson S., Carusi D.A., Gornbein J., The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology, 1994, 44: 2308-2314.
12. Vellas B., Guigoz Y., Garry P.J., Nourhashemi F., Bennahum D., Lauque S., Albarède J.L. The Mini Nutritional Assessment (MNA) and its use in grading the nutritional state of elderly patients, Nutrition, 1999, 15: 116-122.
13. Zarit S.H., Reever K.E., Bach-Peterson J. Relatives of the impaired elderly: correlates of feelings of burden, Gerontologist, 1980, 20: 649-655.
14. Morris J.C., Heyman A., Mohs R.C., et al., The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease, Neurology, 1989, 39: 1159-1165.
15. Guyonnet S., Nourhashemi F., Andrieu S., et al., A prospective study of changes in the nutritional status of Alzheimer's patients. Arch. Gerontol. Geriatr., 1998, Suppl 6: 255-262.
16. Andrieu S., Reynish W., Nourhashemi F., et al., Nutritional risk factors for institutional placement in Alzheimer's disease after one year follow-up. J. Nutr. Health Aging, 2001, 5: 113-117.
17. Rivière S., Gillette-Guyonnet S., Voisin T., et al., A nutritional education program could prevent weight loss and slow cognitive decline in Alzheimer's Disease, J. Nutr. Health Aging, 2001, 5: 295-299.
18. Kukull W.A., Brenner D.E., Speck C.E., et al., Causes of death associated with Alzheimer's disease: variation by level of cognitive impairment before death. J. Am. Geriatr. Soc., 1994, 42: 723-726.
19. Severson M.A., Smith G.E., Tangalos E.G., et al., Patterns and predictors of institutionalization in community-based dementia patients. J. Am. Geriatr. Soc., 1994, 42: 181-185.
20. Knopman D.S., Kitto J., Deinard S., Heiring J., Longitudinal study of death and institutionalization in patients with primary degenerative dementia, J. Am. Geriatr. Soc., 1988, 36: 108-112.
21. Cohen C.A., Gold D.P., Shulman K.I., Wortley J.T., McDonald G., Wargon M., Factors determining the decision to institutionalize dementing individuals: a prospective study, Gerontologist, 1993, 33: 714-720.
22. Seltzer B., Buswell A., Psychiatric symptoms in Alzheimer's disease: mental status examination versus caregiver report, Gerontologist, 1994, 34: 103-109.
23. Corey-Bloom J., Anand R., Veach J., et al. A randomized trial evaluating the efficacy and the safety of ENA 713, a new acetylcholinesterase inhibitor, in patients with mild to moderately severe Alzheimer's disease. Int. J. Geriatr. Psychopharmacol., 1998, 1: 55-56.
24. Rösler M., Anand R., Cicin-Sain, A., et al., Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial. BMJ, 1999, 318: 633-638.
25. Tariot P.N., Solomon P.R., Morris J.C., Kershaw P., Lilienfeld S., Ding C., A 5-month, randomized, placebo-controlled trial of galantamine in AD, Neurology, 2000, 54: 2269-2276.